T-Wave Flattening: Clinical Contexts and Causes
T-wave flattening occurs in multiple clinical contexts including electrolyte abnormalities (particularly hypokalemia and hypocalcemia), myocardial ischemia, drug effects, autonomic nervous system changes, and various cardiac conditions. 1
Primary Causes of T-Wave Flattening
Electrolyte Disturbances
- Hypokalemia is a classic cause, where T-wave flattening occurs alongside ST-segment depression and increased U-wave amplitude, particularly when potassium levels fall below 2.7 mmol/L 2
- Hypocalcemia can also produce T-wave flattening 1
Cardiac Ischemia and Structural Disease
T-wave abnormalities, including flattening, may indicate primary repolarization abnormalities reflecting actual changes in ventricular myocyte repolarization characteristics. These can result from:
- Myocardial ischemia
- Myocarditis
- Ventricular hypertrophy (which causes both primary repolarization changes in myocyte action potentials and secondary changes from QRS alterations) 1, 2
Medications and Toxins
Multiple cardioactive drugs cause T-wave flattening:
- Quinidine-like drugs produce characteristic flattening with ST depression 2
- Flecainide causes distinctive flattened, notched T-waves with a "double hump" appearance at therapeutic doses (200-300 mg/day), which resolves upon discontinuation 3
- Lithium induces T-wave flattening that can be prevented or reversed with spironolactone 4
Autonomic and Physiologic Changes
T-wave flattening occurs with:
- Abrupt heart rate changes
- Hyperventilation
- Body position changes
- Catecholamine surges and sympathetic stimulation
- Temperature changes 1
During anesthesia induction, T-wave flattening correlates with increased heart rate and blood pressure, reflecting heightened sympathetic tone 5
Special Populations
Athletes
Elite athletes demonstrate dynamic T-wave changes during training cycles: T-waves increase in amplitude during low-intensity training periods (up to 130% in males, 100% in females), but transient flattening occurs in 50% of athletes during peak training intensity, without structural cardiac changes 6
Clinical Significance and Risk Stratification
Flat T-waves carry prognostic significance beyond being a benign finding. Recent evidence demonstrates:
In high-risk cardiovascular patients, flat T-waves (defined as amplitude <0.1 mV with T/QRS ratio <10% in ≥2 leads among I, II, aVL, V4-V6) independently predict cardiovascular events with a hazard ratio of 1.52 after adjusting for multiple risk factors 7
In general population studies, flat T-waves associate with 1.81-fold increased sudden cardiac death risk over 10 years, intermediate between normal T-waves and frankly negative T-waves (HR 3.27) 8
In young individuals undergoing cardiac screening, deeper T-wave inversion (>0.183 mV) and involvement of multiple lead territories suggest underlying cardiomyopathy 9
Clinical Pitfalls
Do not dismiss flat T-waves as nonspecific, particularly in leads V4-V6 where they may indicate significant pathology. The distinction between primary and secondary repolarization abnormalities is critical: primary abnormalities indicate actual myocyte dysfunction, while secondary changes (from bundle branch blocks, pacing, or preexcitation) do not 1, 2.
Avoid misdiagnosing ischemia or infarction based solely on isolated T-wave flattening without considering the clinical context, particularly when secondary to conduction abnormalities 2.